NCI Launches M-PACT Next-Generation Trial As Group System Nears March 1 Transition

FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts

NCI announced that the paylines for R01 grants for established and new investigators are expected to drop to the 4th percentile—a historic low for the institute.

July 25, 2025

By Jacquelyn Cobb

Cancer Policy

Right-wing provocateur Laura Loomer comes for FDA’s Vinay Prasad

Laura LoomerVinay PrasadRight-wing activist Laura Loomer is demanding Vinay Prasad’s ouster from FDA, calling him a “saboteur” and “trojan [sic] horse” of the administration’s “Make America Healthy Again” initiative.

July 25, 2025

By Claire Marie Porter

Cancer Policy

The effects of NIH, FDA cuts will be felt for decades, CBO report estimates

A report from the nonpartisan Congressional Budget Office said that proposed cuts at NIH could lead to a decrease in the number of new drugs that come to market in the next three decades.

July 25, 2025

By Paul Goldberg

Cancer Policy

COI statement prohibits “unseemly advocacy,” “undue influence” by industry rep on ODAC

In April, FDA Commissioner Marty Makary said that the presence of industry employees as members of FDA advisory committees “represents a cozy relationship” between FDA and the businesses it regulates.

July 25, 2025

By Paul Goldberg

Cancer Policy

Columbia settles with Trump, agreeing to a $200M fine, as Harvard fights on

It has been more than three months since the Trump Administration froze Columbia University’s NIH funds in an attempt to crack down on “antisemitism.”

July 25, 2025

By Claire Marie Porter and Jacquelyn Cobb